These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2579303)

  • 41. Sodium hypochlorite: a useful therapeutic adjunct for herpes simplex infections.
    Hunter DT
    J Am Med Womens Assoc (1972); 1984; 39(4):135-6. PubMed ID: 6747177
    [No Abstract]   [Full Text] [Related]  

  • 42. [Activity of Isoprinosine in tropical measles (a double blind study involving 200 patients) (author's transl)].
    Gallais H; Kadio A; Odehouri K; Moreau J; Bertrand E
    Bull Soc Pathol Exot Filiales; 1981; 74(5):553-61. PubMed ID: 6172206
    [No Abstract]   [Full Text] [Related]  

  • 43. [Generalization of zona in a nonimmunosuppressed patient receiving isoprinosine and rifamycin SV].
    Revuz J; Guillaume JC; Roujeau JC; Perroud AM
    Ann Dermatol Venereol; 1983; 110(6-7):563. PubMed ID: 6195953
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of herpetic keratitis with metisoprinol. Clinical and histological aspects].
    Gorgone G; Cavallaro N; Scaletta S; Carnazza S; Ricci M; Gala Trinchera G; Cordaro S
    Bull Soc Belge Ophtalmol; 1981; 192():113-23. PubMed ID: 6179556
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of chronic active hepatitis (HBsAg +,HBeAg +) with isoprinosine. Clinical evaluation].
    Cianciara J; Loch T; Babiuch L; Dabrowska-Bernstein B; Stasiak A; Dabrowski M; Pawińska A
    Pol Tyg Lek; 1988 Sep; 43(37):1195-8. PubMed ID: 2470069
    [No Abstract]   [Full Text] [Related]  

  • 46. Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course.
    Beran J; Špajdel M; Slíva J
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Too much hype.
    Viza D
    Nature; 1985 Jan 31-Feb 6; 313(6001):344. PubMed ID: 2578621
    [No Abstract]   [Full Text] [Related]  

  • 48. [Evaluation of the effectiveness of isoprinosine in the treatment of patients with acute viral hepatitis. II. Immunological evaluation].
    Nedoszytko B; Michalska Z; Dubicka M; Gajda A
    Wiad Lek; 1987 Nov; 40(21):1469-74. PubMed ID: 2453975
    [No Abstract]   [Full Text] [Related]  

  • 49. [Isoprinosine in the treatment of virus diseases of the visual system].
    Debicka A
    Klin Oczna; 1987 Jul; 89(7):307-8. PubMed ID: 2447324
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of recurrent herpes simplex virus infection using interferon and isoprinosine].
    Vujosević M; Nikolić S; Bujko M; Zerjav S; Keserović N
    Srp Arh Celok Lek; 1988 Oct; 116(10):875-85. PubMed ID: 2469129
    [No Abstract]   [Full Text] [Related]  

  • 51. [Isoprinosine--a drug with antiviral and immunomodulating action].
    Deroń Z
    Wiad Lek; 1984 Sep; 37(17):1355-61. PubMed ID: 6084363
    [No Abstract]   [Full Text] [Related]  

  • 52. Inosine pranobex-BAN increases the resistance to the challenge with cells or cell-free fluid from Yoshida ascites tumor.
    Fimiani V; Cavallaro A; Falliti G; Amato A
    Chemioterapia; 1986 Apr; 5(2):128-33. PubMed ID: 2423256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Campoli-Richards DM; Sorkin EM; Heel RC
    Drugs; 1986 Nov; 32(5):383-424. PubMed ID: 2431857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imunovir.
    Follezou JY
    Nature; 1985 May 30-Jun 5; 315(6018):364. PubMed ID: 2582267
    [No Abstract]   [Full Text] [Related]  

  • 55. Isoprinosine in SSPE.
    Addy DP
    Neurology; 1980 Nov; 30(11):1255-6. PubMed ID: 6158715
    [No Abstract]   [Full Text] [Related]  

  • 56. AIDS therapy.
    Stephens EJ
    N Z Med J; 1986 Feb; 99(795):72-3. PubMed ID: 2418393
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro studies on cell-mediated immunity in patients treated with inosiplex for herpes virus infection.
    Bradshaw LJ; Sumner HL
    Ann N Y Acad Sci; 1977 Mar; 284():190-6. PubMed ID: 81637
    [No Abstract]   [Full Text] [Related]  

  • 58. Herpes simplex viruses 1 and 2.
    Ruderfer D; Krilov LR
    Pediatr Rev; 2015 Feb; 36(2):86-90. PubMed ID: 25646316
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study.
    De Simone C; Albertini F; Almaviva M; Angarano G; Chiodo F; Costigliola P; Delia S; Ferlini A; Gritti F; Mazzarello G
    Med Oncol Tumor Pharmacother; 1989; 6(1):63-7. PubMed ID: 2471025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Immunostimulative therapy of herpes zoster (three years' experience with inosiplex) (author's transl)].
    Bunta S; Peris Z
    Z Hautkr; 1981 Nov; 56(22):1457-66. PubMed ID: 6171939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.